173 related articles for article (PubMed ID: 35936729)
1. Accuracy of ultrasonographic changes during neoadjuvant chemotherapy to predict axillary lymph node response in clinical node-positive breast cancer patients.
Li Z; Tong Y; Chen X; Shen K
Front Oncol; 2022; 12():845823. PubMed ID: 35936729
[TBL] [Abstract][Full Text] [Related]
2. Nomogram for predicting axillary lymph node status after neoadjuvant chemotherapy in breast cancer.
Wang M; Wang M; Wang Z; Song Y; Gao P; Wang P; Wang C; Yu X; Wei F; Guo J; Xu Y
Transl Cancer Res; 2020 Nov; 9(11):7054-7064. PubMed ID: 35117311
[TBL] [Abstract][Full Text] [Related]
3. Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy.
Maimaitiaili A; Chen H; Xie P; Liu Z; Ling R; Zhao Y; Yang H; Liu Y; Liu K; Zhang J; Mao D; Yu Z; Liu Y; Fu P; Wang J; Jiang H; Zhao Z; Tian X; Cao Z; Wu K; Song A; Jin F; He J; Fan Z; Zhang H
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8769-8778. PubMed ID: 37129606
[TBL] [Abstract][Full Text] [Related]
4. Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy.
Wang W; Wang X; Liu J; Zhu Q; Wang X; Wang P
Chin Med J (Engl); 2021 Dec; 135(3):333-340. PubMed ID: 35108228
[TBL] [Abstract][Full Text] [Related]
5. Combining conventional ultrasound and sonoelastography to predict axillary status after neoadjuvant chemotherapy for breast cancer.
Huang JX; Lin SY; Ou Y; Shi CG; Zhong Y; Wei MJ; Pei XQ
Eur Radiol; 2022 Sep; 32(9):5986-5996. PubMed ID: 35364714
[TBL] [Abstract][Full Text] [Related]
6. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients.
Eun NL; Son EJ; Gweon HM; Kim JA; Youk JH
Eur Radiol; 2020 Mar; 30(3):1460-1469. PubMed ID: 31802216
[TBL] [Abstract][Full Text] [Related]
7. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
[No Abstract] [Full Text] [Related]
8. Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis.
Ryu JM; Lee SK; Kim JY; Yu J; Kim SW; Lee JE; Han SH; Jung YS; Nam SJ
Clin Breast Cancer; 2017 Nov; 17(7):550-558. PubMed ID: 28454926
[TBL] [Abstract][Full Text] [Related]
9. Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer.
Choi HJ; Ryu JM; Kim I; Nam SJ; Kim SW; Yu J; Lee JE; Lee SK
Ann Surg Treat Res; 2019 Apr; 96(4):169-176. PubMed ID: 30941320
[TBL] [Abstract][Full Text] [Related]
10. Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer.
Kim R; Chang JM; Lee HB; Lee SH; Kim SY; Kim ES; Cho N; Moon WK
Radiology; 2019 Oct; 293(1):49-57. PubMed ID: 31407967
[TBL] [Abstract][Full Text] [Related]
11. Prediction of axillary lymph node pathological complete response to neoadjuvant therapy using nomogram and machine learning methods.
Zhou T; Yang M; Wang M; Han L; Chen H; Wu N; Wang S; Wang X; Zhang Y; Cui D; Jin F; Qin P; Wang J
Front Oncol; 2022; 12():1046039. PubMed ID: 36353547
[TBL] [Abstract][Full Text] [Related]
12. Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).
Le-Petross HT; McCall LM; Hunt KK; Mittendorf EA; Ahrendt GM; Wilke LG; Ballman KV; Boughey JC
AJR Am J Roentgenol; 2018 Mar; 210(3):669-676. PubMed ID: 29381381
[TBL] [Abstract][Full Text] [Related]
13. Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer.
Vila J; Mittendorf EA; Farante G; Bassett RL; Veronesi P; Galimberti V; Peradze N; Stauder MC; Chavez-MacGregor M; Litton JF; Huo L; Kuerer HM; Hunt KK; Caudle AS
Ann Surg Oncol; 2016 Oct; 23(11):3501-3509. PubMed ID: 27216742
[TBL] [Abstract][Full Text] [Related]
14. Laboratory indicators predict axillary nodal pathologic complete response after neoadjuvant therapy in breast cancer.
Chen P; Zhao T; Bi Z; Zhang ZP; Xie L; Liu YB; Song XG; Song XR; Wang CJ; Wang YS
Future Oncol; 2021 Jul; 17(19):2449-2460. PubMed ID: 33878939
[TBL] [Abstract][Full Text] [Related]
15. A nomogram for predicting axillary pathologic complete response in hormone receptor-positive breast cancer with cytologically proven axillary lymph node metastases.
Guo R; Su Y; Si J; Xue J; Yang B; Zhang Q; Chi W; Chen J; Chi Y; Shao Z; Wu J
Cancer; 2020 Aug; 126 Suppl 16():3819-3829. PubMed ID: 32710664
[TBL] [Abstract][Full Text] [Related]
16. Elaboration and Validation of a Nomogram Based on Axillary Ultrasound and Tumor Clinicopathological Features to Predict Axillary Lymph Node Metastasis in Patients With Breast Cancer.
Liu Y; Ye F; Wang Y; Zheng X; Huang Y; Zhou J
Front Oncol; 2022; 12():845334. PubMed ID: 35651796
[TBL] [Abstract][Full Text] [Related]
17. Axillary Pathologic Complete Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer Patients: A Predictive Model Integrating the Imaging Characteristics of Ultrasound Restaging with Known Clinicopathologic Characteristics.
Kim WH; Kim HJ; Park HY; Park JY; Chae YS; Lee SM; Cho SH; Shin KM; Lee SY
Ultrasound Med Biol; 2019 Mar; 45(3):702-709. PubMed ID: 30567630
[TBL] [Abstract][Full Text] [Related]
18. Application of the Z1071 criteria: classification of axillary lymph nodes on ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer.
Iwamoto N; Miyamoto H; Horiguchi S; Honda Y; Aruga T
J Med Ultrason (2001); 2020 Apr; 47(2):299-303. PubMed ID: 32112307
[TBL] [Abstract][Full Text] [Related]
19. A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012).
Maimaitiaili A; Li Y; Chai N; Liu Z; Ling R; Zhao Y; Yang H; Liu Y; Liu K; Zhang J; Mao D; Yu Z; Liu Y; Fu P; Wang J; Jiang H; Zhao Z; Tian X; Cao Z; Wu K; Song A; Jin F; Wu P; He J; Fan Z; Zhang H
Front Oncol; 2024; 14():1326385. PubMed ID: 38800388
[TBL] [Abstract][Full Text] [Related]
20. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
